Personalized immune cell vaccine for brain tumors
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a personalized vaccine made from your own immune cells (a dendritic cell vaccine) that may help your body fight the brain tumor. It is meant for people with DIPG or glioblastoma who have already tried standard treatments but still have tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 6 months and 80 years old.
- You must have a type of brain tumor called DIPG or glioblastoma that is still visible on a scan.
- You must have already received standard treatments like surgery, radiation, and chemotherapy (temozolomide).
- Your seizures (if any) must be well controlled, and you must be in good enough overall health to function at least 60% on the Karnofsky scale.
- Your heart, lungs, kidneys, and liver must be working well enough, and you must have adequate blood counts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized vaccine made from your own immune cells (dendritic cells) to help your body fight advanced cancer. It is for people whose cancer has not responded to other treatments.
This trial tests a vaccine made from your own immune cells to fight glioblastoma, a type of brain cancer. It may help your body attack the cancer more effectively after standard treatments.
This trial tests an experimental 'vaccine' made from your own immune cells (dendritic cells). The vaccine is designed to train your immune system to attack the brain tumor. It is for people whose glioblastoma has returned or progressed after standard treatment.
This trial offers a personalized vaccine (DCVax-L) made from your own tumor cells to patients with glioblastoma (a type of brain cancer) who were not able to join a previous study. The vaccine aims to help your immune system fight the cancer.
This trial tests a personalized vaccine made from your own tumor cells, given after standard treatment (surgery and chemo/radiation) for newly diagnosed glioblastoma. The vaccine aims to train your immune system to fight any remaining cancer cells.
This trial tests a personalized vaccine created by AI to target your specific brain tumor. It is for people with a glioma that came back after standard treatments like surgery, radiation, or chemotherapy, and whose tumor has enough genetic mutations to make the vaccine.
Hear when a new Diffuse Intrinsic Pontine Glioma or Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.